Cargando…

Amantadine in Treatment of Dysthymia—The Pilot Case Series Study

Dysthymia is a common chronic mood disorder in which isolated symptoms of depression persist for at least 2 years. Despite the many medications recommended for the treatment of dysthymia, no recommendations have yet been made for the treatment of patients who fail to achieve clinical improvement. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzystanek, Marek, Martyniak, Ewa, Pałasz, Artur, Skałacka, Katarzyna, Chwalba, Artur, Wierzbiński, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301632/ https://www.ncbi.nlm.nih.gov/pubmed/37375844 http://dx.doi.org/10.3390/ph16060897

Ejemplares similares

Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2021)

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2020)

Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
por: Krzystanek, Marek, et al.
Publicado: (2020)

The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study
por: Krzystanek, Marek, et al.
Publicado: (2020)

Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study
por: Murawiec, Sławomir, et al.
Publicado: (2021)

Treatment Compliance in the Long-Term Paranoid Schizophrenia Telemedicine Study
por: Krzystanek, Marek, et al.
Publicado: (2017)

Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study
por: Krzystanek, Marek, et al.
Publicado: (2020)

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
por: Krzystanek, Marek, et al.
Publicado: (2019)

Spider Neurotoxins as Modulators of NMDA Receptor Signaling
por: Pałasz, Artur, et al.
Publicado: (2021)

Antipsychotics increase steroidogenic enzyme gene expression in the rat brainstem
por: Bogus, Katarzyna, et al.
Publicado: (2021)

Dysthymia and Apathy: Diagnosis and Treatment
por: Ishizaki, Junko, et al.
Publicado: (2011)

Olanzapine Increases Neural Chemorepulsant—Draxin Expression in the Adult Rat Hippocampus
por: Pałasz, Artur, et al.
Publicado: (2021)

Proctalgia fugax with dysthymia
por: Singh, Gurvinder Pal
Publicado: (2006)

Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
por: Krzystanek, Marek, et al.
Publicado: (2021)

Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
por: Piwowarczyk-Nowak, Aneta, et al.
Publicado: (2022)

Olanzapine alters the expression of gasotransmitter-related enzymes: CBS and HO-2 in the rat hippocampus and striatum
por: Pałasz, Artur, et al.
Publicado: (2023)

Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain
por: Bogus, Katarzyna, et al.
Publicado: (2019)

Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment
por: Krzystanek, Marek, et al.
Publicado: (2020)

Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem
por: Pałasz, Artur, et al.
Publicado: (2021)

Infra-Low-Frequency Neurofeedback Treatment in Dysthymia: A Case Study
por: Tschiesner, Reinhard
Publicado: (2023)

Dysthymia through time: A review
por: Valadas, M.T., et al.
Publicado: (2021)

Effect of long-term treatment with classical neuroleptics on NPQ/spexin, kisspeptin and POMC mRNA expression in the male rat amygdala
por: Pałasz, Artur, et al.
Publicado: (2018)

CRY2 Genetic Variants Associate with Dysthymia
por: Kovanen, Leena, et al.
Publicado: (2013)

Use of amantadine in the evaluation of response to chemotherapy in lung cancer: a pilot study
por: Maksymiuk, Andrew W, et al.
Publicado: (2021)

Depressive and Other Adverse CNS Effects of Fluoroquinolones
por: Wierzbiński, Piotr, et al.
Publicado: (2023)

Amantadine use in pediatric Catatonia: A case series
por: dhankar, Mondeep, et al.
Publicado: (2022)

β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes
por: Chwalba, Artur, et al.
Publicado: (2021)

Escitalopram as a modulator of proopiomelanocortin, kisspeptin, Kiss1R and MCHR1 gene expressions in the male rat brain
por: Pałasz, Artur, et al.
Publicado: (2020)

Chlorpromazine affects the numbers of Sox-2, Musashi1 and DCX-expressing cells in the rat brain subventricular zone
por: Skałbania, Jakub, et al.
Publicado: (2021)

Affective Personality Traits in Olfactory Dysfunction: the Role of Dysthymia and Arousal
por: Schienle, Anne, et al.
Publicado: (2017)

Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2020)

Amantadine in the Treatment of Pathological Gambling: A Case Report
por: Pettorruso, Mauro, et al.
Publicado: (2012)

Observational study of people infected with SARS-Cov-2, treated with amantadine
por: Aranda-Abreu, Gonzalo Emiliano, et al.
Publicado: (2020)

Amantadine Treatment for People with COVID-19
por: Araújo, Ramiro, et al.
Publicado: (2020)

The Effect of Amantadine on Agitation in the Pediatric Traumatic Brain Injury Population: A Case Series
por: Hon, Emily, et al.
Publicado: (2023)

Temporal relationship between dysthymia and temporomandibular disorder: a population-based matched case-control study in Taiwan
por: Lin, Shang-Lun, et al.
Publicado: (2017)

Effects of stressor controllability on psychophysiological, cognitive and behavioural responses in patients with major depression and dysthymia
por: Diener, C., et al.
Publicado: (2009)

Secular trends in the incidence of major depressive disorder and dysthymia in China from 1990 to 2019
por: Li, Ming, et al.
Publicado: (2023)

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
por: Cortés-Borra, Albert, et al.
Publicado: (2021)

Amantadine for the Treatment of Refractory Absence Seizures in Children
por: Sreedharan, Mini, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c05tnkhfogg39b1ur8ffv25tjv